Feed aggregator

LOS ANGELES--(BUSINESS WIRE)---- $EXEL--EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $ONT--ONT Investors Have Opportunity to Join Onterris, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $TENX--TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $SION--SION Investors Have Opportunity to Join Sionna Therapeutics, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $NABL--NABL Investors Have Opportunity to Join N-able, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $WDAY--WDAY Investors Have Opportunity to Join Workday, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $UWMC--UWMC Investors Have Opportunity to Lead UWM Holdings Corporation Securities Fraud Lawsuit with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $HDB--HDFC Bank Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – HDB

LOS ANGELES--(BUSINESS WIRE)---- $HDB--HDB Investors Have Opportunity to Lead HDFC Bank Limited Securities Fraud Lawsuit with SBS Law

NEW YORK--(BUSINESS WIRE)---- $AARD #AARD--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aardvark Therapeutics, Inc. (“Aardvark” or the “Company”) (NASDAQ: AARD) and reminds investors of the October 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgi

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Theravance Biopharma, Inc. (NASDAQ: TBPH) to Zymeworks Inc. for $17.00 per share. Halper Sadeh encourages Theravance shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Theravance and its board of directors violat

NEW YORK--(BUSINESS WIRE)--Investcorp Credit Management BDC, Inc. (NASDAQ: ICMB) (“ICMB” or the “Company”) announced its financial results today for its fiscal quarter ended June 30, 2026. HIGHLIGHTS ICMB fully realized investments in five portfolio companies during the quarter, totaling $13.9 million in proceeds. The internal rate of return on these investments was 7.73%. During the quarter, ICMB made a $2.3 million at cost investment in an existing portfolio company. During the quarter, the C

SAN DIEGO--(BUSINESS WIRE)---- $SMPL #SMPL--Robbins LLP is investigating whether The Simply Good Foods Company misled investors regarding the successful integration of OWYN.

NEW YORK--(BUSINESS WIRE)---- $HDB #ClassActionLawsuit--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired HDFC Bank Limited (“HDFC” or the “Company”) (NYSE: HDB) securities during the period of July 17, 2023 through May 26, 2026, inclusive (“the Class Period”). Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the s

SAN DIEGO--(BUSINESS WIRE)---- $BE #AlternativeEnergy--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Bloom Energy Corporation (NYSE: BE) securities between February 27, 2025 and July 8, 2026 (the "Class Period"). Bloom Energy designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation in the United States and internationally. Scandium is a rare earth metal used as a dopant to

SAN DIEGO--(BUSINESS WIRE)---- $AARD #Health--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) (a) common stock pursuant to the Company's February 13, 2025 initial public offering ("IPO") and/or (b) securities between February 13, 2025 and May 14, 2026 (the "Class Period"). Aardvark is a clinical-stage biopharmaceutical company that focuses on developing smal

SAN DIEGO--(BUSINESS WIRE)---- $RXT #AI--Robbins LLP informs investors that a securities class action has been filed on behalf of persons and entities that purchased or otherwise acquired Rackspace Technology, Inc. (NASDAQ: RXT) securities between May 7, 2026 and July 8, 2026, inclusive (the "Class Period"). Rackspace is a hybrid cloud and AI solutions company that owns and operates physical infrastructure to host cloud services and artificial intelligence. Investors who suffered significant losses during t

SAN DIEGO--(BUSINESS WIRE)---- $HTZ #Car--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons who purchased or otherwise acquired Hertz Global Holdings, Inc. (NASDAQ: HTZ) common stock between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). Investors who suffered significant losses during the Class Period may be eligible to participate in the lawsuit and should be aware of the upcoming September 22, 2026 deadline to seek appointment as

PARK CITY, Utah--(BUSINESS WIRE)--WEBs Investments Inc. (WEBs) announced today its intention to close 11 series within its Defined Volatility Sector ETFs suite of funds: WEBs Energy XLE Defined Volatility ETF, WEBs Materials XLB Defined Volatility ETF, WEBs Industrials XLI Defined Volatility ETF, WEBs Consumer Discretionary XLY Defined Volatility ETF, WEBs Consumer Staples XLP Defined Volatility ETF, WEBs Health Care XLV Defined Volatility ETF, WEBs Financial XLF Defined Volatility ETF, WEBs Te

SAN DIEGO--(BUSINESS WIRE)---- $BABA #Alibaba--The case alleges Alibaba Group and certain of its executives made false and/or misleading statements to investors.